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Cellular form of prion protein inhibits Reelin-mediated shedding
of Caspr from the neuronal cell surface to potentiate
Caspr-mediated inhibition of neurite outgrowth
Abstract
Extension of axonal and dendritic processes in the CNS is tightly regulated by outgrowth-promoting and
-inhibitory cues to assure precision of synaptic connections. We identify a novel role for
contactin-associated protein (Caspr) as an inhibitory cue that reduces neurite outgrowth from CNS
neurons. We show that proteolysis of Caspr at the cell surface is regulated by the cellular form of prion
protein (PrP), which directly binds to Caspr. PrP inhibits Reelin-mediated shedding of Caspr from the
cell surface, thereby increasing surface levels of Caspr and potentiating the inhibitory effect of Caspr on
neurite outgrowth. PrP deficiency results in reduced levels of Caspr at the cell surface, enhanced neurite
outgrowth in vitro, and more efficient regeneration of axons in vivo following spinal cord injury. Thus,
we reveal a previously unrecognized role for Caspr and PrP in inhibitory modulation of neurite
outgrowth in CNS neurons, which is counterbalanced by the proteolytic activity of Reelin.
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Extension of axonal and dendritic processes in the CNS is tightly regulated by outgrowth-promoting and -inhibitory cues to assure
precision of synaptic connections. We identify a novel role for contactin-associated protein (Caspr) as an inhibitory cue that reduces
neurite outgrowth from CNS neurons. We show that proteolysis of Caspr at the cell surface is regulated by the cellular form of prion
protein (PrP), which directly binds to Caspr. PrP inhibits Reelin-mediated shedding of Caspr from the cell surface, thereby increasing
surface levels of Caspr and potentiating the inhibitory effect of Caspr on neurite outgrowth. PrP deficiency results in reduced levels of
Caspr at the cell surface, enhanced neurite outgrowth in vitro, and more efficient regeneration of axons in vivo following spinal cord
injury. Thus, we reveal a previously unrecognized role for Caspr and PrP in inhibitorymodulation of neurite outgrowth in CNS neurons,
which is counterbalanced by the proteolytic activity of Reelin.
Introduction
Cellular prion protein (PrP) is an adhesion molecule impli-
cated in neuronal survival, neurite outgrowth (Chen et al.,
2003; Santuccione et al., 2005), and synaptic function (Collinge et
al., 1994). This functional feature of PrP is consistent with its associ-
ationwith several cell surface proteins involved in regulationof neu-
ral development, including the 67 kDa laminin receptor, the 37
kDa laminin receptor precursor protein, and the extracellular
matrix glycoprotein laminin (Rieger et al., 1997; Graner et al.,
2000; Gauczynski et al., 2001). PrP also occurs in a complex with
the neural cell adhesion molecule (NCAM) (Schmitt-Ulms et al.,
2001) that results from cis- and trans-interactions between PrP
and NCAM at the neural cell surface (Santuccione et al., 2005).
PrP promotes recruitment of NCAM to lipid rafts and thereby
regulates activation of fyn kinase, an enzyme implicated in
NCAM- and PrP-mediated intracellular signaling (Beggs et al.,
1994, 1997; Mouillet-Richard et al., 2000; Bodrikov et al., 2005,
2008). PrP also associates with the 2/2-Na
/K-ATPase,
which in turn associates with the Ig superfamily adhesion mole-
cule basigin (Kleene et al., 2007). This complex between PrP,
2/2-ATPase, and basigin regulates the transport of lactate in
astrocytes via the monocarboxylate transporter 1, which is acti-
vated by the synaptic GluR2 subunit-containing AMPA receptor
with which PrP also interacts (Kleene et al., 2007).
It is conceivable that reduction in the functions of PrP by its
conversion into the pathological form (PrPscrapie) renders the
cellular form of PrP less available to the normal cellular func-
tions, thereby contributing to the pathology of prion diseases.
Since an understanding of prion diseases also depends on the
identification of binding partners for the cellular form of prion
protein and the characterization of their functional properties,
we searched for other binding partners of PrP with the aim of
widening our understanding of the functions of PrP in the con-
text of its interactions with molecules at the cell surface and/or in
the extracellular matrix.
Here, we report on the interaction of PrP and contactin-
associated protein (Caspr) (Peles et al., 1997). Caspr is most well
characterized as an adhesion molecule that is required for the
formation of axoglial paranodal junctions surrounding the nodes
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of Ranvier in myelinated axons (Einheber et al., 1997; Scherer,
1999; Peles and Salzer, 2000). We now show a novel function for
Caspr as a negative regulator of neurite outgrowth in CNS neu-
rons. While it was shown previously that Caspr associates in
cis-interaction with the glycosylphosphatidyl inositol (GPI)-
anchored neural cell adhesionmolecule contactin/F3 (Peles et al.,
1997), which is required for the transport of Caspr to the cell
surface (Faivre-Sarrailh et al., 2000), we provide evidence that the
interactionwithGPI-anchoredPrPpreventsCaspr fromsheddingat
the cell surface. Furthermore, we identified Reelin, an extracellular
matrix glycoproteinwith protease activity (Quattrocchi et al., 2002),
as an enzyme involved in shedding of Caspr. Thus, we reveal a pre-
viously unrecognized role for Caspr and PrP in inhibitory modula-
tion of neurite outgrowth in neurons, which is counterbalanced by
the proteolytic activity of Reelin.
Materials andMethods
Antibodies.Mousemonoclonal antibody 8H4 against PrP, a generous gift
from Dr. Man Sun Sy (Case Western Reserve University, Cleveland,
OH), was used for immunocytochemistry and immunohistochemsitry.
The specificity of the antibody was verified in PrP-transfected Chinese
hamster ovary (CHO) cells (supplemental Fig. S1, available at www.
jneurosci.org as supplemental material) and PrP/ brains. Rat mono-
clonal antibody 555 against L1 (Appel et al., 1993) was used for
immunocytochemistry and immunoblotting. Rabbit polyclonal anti-
bodies against the extracellular domain of Caspr (L23, L17), a kind gift
from Cathe´rine Faivre-Sarrailh (Institut Jean-Roche, Marseille, France),
were used for immunocytochemistry and neurite outgrowth experi-
ments. Polyclonal goat antibodies against the N terminus of Caspr (N15)
from Santa Cruz Biotechnology were used for immunocytochemistry,
Western blot, and neurite outgrowth experiments. Goat polyclonal anti-
bodies against PrP (M20) (Santa Cruz Biotechnology) were used for
immunoprecipitation andWestern blot analysis.Mousemonoclonal an-
tibody against Reelin (Millipore) was used for Western blot analysis and
immunohistochemistry. Polyclonal rabbit and monoclonal mouse
antibodies against calbindin (Sigma) were used for immunohisto-
chemistry. ForWestern blot we also used polyclonal rabbit antibodies
against the FGF receptor (Flg) (Santa Cruz Biotechnology), poly-
clonal rabbit antibodies against CHL1 (Leshchyns’ka et al., 2006),
polyclonal rabbit antibodies against actin and mouse monoclonal
antibodies against tubulin (Sigma), polyclonal goat antibodies
against contactin (R & D Systems), mouse monoclonal antibody
against glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and
rabbit polyclonal antibodies against 5-hydroxytryptamine trans-
porter (5-HT) and tyrosine hydroxylase (TH) (Millipore). Secondary
antibodies against goat, rabbit, rat, and mouse Igs coupled to Cy2,
Cy3, Cy5, or HRP were from Dianova.
Production of the polyclonal antibodies against the intracellular domain
of Caspr. Polyclonal antibodies against the intracellular domain of Caspr
were generated by immunizing rabbits with a peptide derived from the
Caspr intracellular domain (H-APGPRDQNLPQILEESRSEC-OH).
Imject Maleimide Activated McKLH kit (Pierce) was used for conjugat-
ing the peptide to a carrier protein for animal injections. Rabbits were
killed after five boosts and the blood was collected and processed to
collect the serum. Antiserum thus obtained was purified further by affin-
ity chromatography using protein G-Sepharose 4 fast flow column.
Bound antibodies were eluted using 0.1 M glycine (pH 2.7–3.0). Eluted
material was neutralized with 1 M Tris-HCl, pH 8.8, and dialyzed exten-
sively against PBS, pH 7.3. The specificity of the purified antibodies was
confirmed in Caspr transfected CHO cells (supplemental Fig. S1, avail-
able at www.jneurosci.org as supplemental material). The antibodies
were used for biochemical, histochemical, and cytochemical studies.
Animals. PrP/mice (Bueler et al., 1992) were generously provided
byDr.MartinH. Groschup (Institute for Novel and Emerging Infectious
Diseases, Greifswald, Germany). Caspr/ mice were as described pre-
viously (Gollan et al., 2003). Young (10 d old) or adult (6–10 week old)
wild-type, PrP/, and Caspr/ animals were used as indicated in the
text. Brains of 10-d-old Reelin/ and Reelin/mice were generously
provided by Dr. Michael Frotscher and Dr. Shanting Zhao (Institute for
Anatomy and Cell Biology, Albert-Ludwigs-University of Freiburg,
Freiburg, Germany).
Plasmids. The Reelin plasmidwas a kind gift fromDr. TomCurran (St.
JudeChildren’s ResearchHospital,Memphis, TN). The full-lengthCaspr
plasmid was as described previously (Peles et al., 1997). Caspr-Fc encod-
ing the extracellular domain of rat Caspr fused to humanFc (Gollan et al.,
2003) was subcloned into pcDNA3 and used to transfect CHO cells that
secrete this protein into the culture medium. The contactin plasmid was
a kind gift from Dr. Gianfranco Gennarini (University of Bari, Bari,
Italy). PrP plasmids were kind gifts of Dr. Sylvain Lehmann (Institut de
Ge´ne´tique Humaine du CNRS, Montpellier, France).
Purification of Caspr. Caspr was purified from brain homogenates us-
ing polyclonal antibodies against the intracellular domain of Caspr with
the Bio-Rad Econo system. Antibodies were coupled to cyanogen
bromide-activated Sepharose according to the manufacturer’s instruc-
tions (GE Healthcare). Brains from adult mice were homogenized in
buffer containing 5 mM Tris, pH 7.5, 0.32 M sucrose, 1 mM CaCl2, 1 mM
MgCl2, and 1 mM NaHCO3, 0.5% Nonidet P-40, and EDTA-free Com-
plete Protease Inhibitor Cocktail (Roche) and centrifuged at 2000 g for
15min at 4°C. The supernatant was then collected and lysed overnight at
4°C by adding N-octylglucoside and Triton X-100 to a final concentra-
tion of 1 and 0.5%, respectively. The lysate was centrifuged at 50,000 g
for 1 h at 4°C. The resulting supernatant was collected and applied to the
column containing immobilized polyclonal antibodies against Caspr.
Bound proteins were eluted with 50 mM ethanolamine, pH 11.5, 150 mM
NaCl,and0.2%3-[(3-cholamidopropyl)dimethylammonio]-1-propane-
sulfonate and immediately neutralized with 1 M Tris-HCl, pH 6.8.
Protein-containing fractions were collected, dialyzed overnight at 4°C
against TBS, and verified for the presence of Caspr by SDS-PAGE, fol-
lowed by silver staining.
ELISA. L1-Fc (2g/ml) (Chen et al., 1999), PrP-Fc (2g/ml) (Chen et
al., 2003), and BSA (2g/ml) were immobilized on the polyvinylchloride
surface of a 96-well microtiter plate in PBS overnight at 4°C. Nonab-
sorbed proteins were removed andwells werewashed five times for 5min
at room temperature (RT) with PBS containing 0.05% Tween 20 (PBS-
T). Wells were blocked for 1 h at RT with 1% BSA in PBS and subse-
quently incubated with different concentrations of Caspr (0–2g/ml) in
PBS-T containing 3% BSA for 2 h at RT. Wells were then washed five
times for 5 min each at RT with PBS-T, and bound Caspr was detected
with Caspr antibodies followed by HRP-conjugated secondary antibodies
visualized by detecting HRP with 2,2-azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid reagent,which resulted inacoloredproduct thatwasquantified
using an ELISA reader at 405 nm.
Brain and spinal cord homogenate preparation. Whole brains or the
5-mm-long segments from the spinal cord lesion scar were taken for
analysis. Homogenates were prepared using a Potter homogenizer in 50
mM Tris-HCl buffer, pH 7.5, containing 0.32 M sucrose, 1 mM CaCl2, 1
mM MgCl2, 1 mM NaHCO3, and Complete Protease Inhibitor Cocktail
(Roche).
Isolation of the total membrane fraction. Brain homogenates were pre-
pared using a Potter homogenizer in HOMO buffer (1 mMMgCl2, 1 mM
CaCl2, 1 mM NaHCO3, 5 mM Tris, 0.32 M sucrose, pH 7.4) and centri-
fuged at 700  g for 10 min at 4°C. The resulting supernatants were
centrifuged at 100,000 g at 4°C for 30 min. Pellets containing the total
membrane fraction were used for further analyses.
Isolation of growth cones. Growth cones were isolated as described
previously (Pfenninger et al., 1983). Brain homogenates from 1- to 3-d-
oldmice were centrifuged at 1660 g for 15min at 4°C. The supernatant
was collected and centrifuged on a discontinuous density gradient of
0.75/1.0/2.66 M sucrose at 242,000  g for 40 min at 4°C. The interface
between the load and 0.75 M sucrose containing growth cones was col-
lected, resuspended in 10 ml of HOMO buffer, and pelleted by centrifu-
gation at 100,000 g for 40 min at 4°C to obtain purified growth cones.
Coimmunoprecipitation. Homogenates (1 mg of protein) were lysed
for 30 min in 50 mM Tris-HCl buffer, pH 7.5, containing 150 mM NaCl,
1%Nonidet P-40, 1% octyl-D-glucopyranoside or 0.5% SDS, 1 mMNaF,
2 mM Na3VO4, 0.1 mM PMSF, and EDTA-free Protease Inhibitor Cock-
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tail (Roche). The lysis buffer containing this combination of detergents
completely solubilizes lipid rafts andhas beenused in a number of studies
involving coimmunoprecipitation of lipid raft components (Trupp et al.,
1999; Paratcha et al., 2001; Santuccione et al., 2005). Samples were then
centrifuged for 15 min at 20,000 g and 4°C. Supernatants were cleared
with protein A/G-agarose beads (Santa Cruz Biotechnology) for 3 h at
4°C and incubated with respective primary antibodies overnight at 4°C,
followed by precipitation with protein A/G-agarose beads applied for 3 h
at 4°C. The beads were washed three times with lysis buffer and oncewith
PBS, and bound proteins analyzed by immunoblotting.
Western blot analysis. Samples were mixed with sample buffer and
boiled for 5–7 min. Proteins were separated by electrophoresis on 8, 10,
or 12% SDS-polyacrylamide gels, depending on the molecular weight of
the proteins that were analyzed, and transferred to a nitrocellulosemem-
brane (GE Healthcare). Membranes were blocked with 5% milk in PBS,
incubated with primary antibodies overnight at 4°C (or for 3 d at 4°C for
supernatant analysis) with shaking and washed with PBS. Primary anti-
bodies were detected with corresponding HRP-conjugated secondary
antibodies applied for 1 h in 5% milk in PBS. After washing, secondary
antibodies were visualized with chemiluminescence.
In vitro proteolytic processing by Reelin. Caspr-Fc, or Caspr or L1 puri-
fied from mouse brain were incubated at 37°C for 2 h with Reelin-
containing culture medium from CHO cells transfected with full-length
Reelin ormedium fromCHO cells transfected with pcDNA3 for control.
Samples were then resuspended in sample buffer, boiled for 8 min, and
analyzed by Western blot.
Cerebellar granule cell cultures. Dissociated granule cell cultures were
prepared from the cerebellum of 6- to 8-d-old wild-type, PrP/, and
Caspr/mice as described previously (Chen et al., 1999).
CHO cell culture. CHO cells were maintained in Glasgow modified
Eagle’s medium containing 10% fetal calf serum and transfected using
Lipofectamine with Plus reagent (Invitrogen) following the manufac-
turer’s instructions.
Immunocytochemistry. Indirect immunofluorescence staining was
performed as described previously (Sytnyk et al., 2002; Leshchyns’ka et
al., 2003). Neurons on glass coverslips were washed in PBS and fixed in
4% formaldehyde in PBS for 15 min at RT. Neurons were then washed
three times with PBS, permeabilized with 0.25% Triton X-100 in PBS
applied for 5 min, blocked in 1% BSA in PBS, and incubated with pri-
mary antibodies diluted in 1% BSA in PBS for 1 h. Primary antibodies
were detected with corresponding secondary antibodies applied in 1%
BSA in PBS for 30 min. To detect Caspr at the cell surface, polyclonal
antibodies against the extracellular domain of Caspr were applied to live
neurons for 20 min in culture medium in a CO2 incubator, followed by
secondary antibodies applied for 15 min in culture medium in a CO2
incubator. In cocapping experiments, antibodies against the extracellular
domains of PrP and Caspr were applied together in culture medium for
15 min, followed by secondary antibodies applied in culture medium for
15 min in a CO2 incubator. Coverslips were embedded in Aqua-Poly/
Mount (Polysciences). Images were acquired at RT using a confocal
laser-scanning microscope TCS-SP2 (Leica) using a 63 objective. The
images were exported using LSM510 software (version 3; Zeiss).
Neurite outgrowth assay. Cells were maintained in 12-well plates
(Nunc) on glass coverslips (15 mm in diameter; Hecht) substrate coated
with poly-L-lysine (Sigma) followed, when indicated, with Caspr anti-
bodies (1 g/ml), laminin (Sigma; 1 g/ml), or PrP-Fc (1 g/ml) and
cultured in chemically defined serum-free medium (Chen et al., 1999).
Where indicated, aprotinin (1 M) was added to the medium. Twenty-
two hours after seeding, cells were fixed for 15 min with 2.5% glutaral-
dehyde in PBS and stained with toluidine blue/trypan blue. The total
length of all neurites per neuron was measured by the KS image analysis
system (Kontron-Zeiss). At least three coverslips for each group were
taken in each experiment, and at least 100 cells from one coverslip were
analyzed. Experiments were repeated three times.
Analysis of Caspr shedding into the culture medium. Inhibitors [aproti-
nin (1 M; Sigma), pepstatin (1 M; Sigma), phenanthrolamine (10 M;
Sigma), GM6001 (1 M; Merck)] or PrP-Fc (1 g/ml) were applied 6 h
after plating of cells. Cells were maintained for 5 d by replacing medium
and inhibitors or PrP-Fc every second day. Culture medium was then
collected. Proteins in the culture medium were concentrated by Amicon
columns with a 10 kDamolecular weight cutoff (Millipore) and used for
Western blot analysis.
Cell surface biotinylation. Surface biotinylation was performed as de-
scribed previously (Schmidt et al., 1997) withmodifications. Briefly, 48 h
after transfection cells were washed twice with ice-cold PBS supple-
mented with 0.5 mM CaCl2 and 2 mMMgCl2 (PBSCM). Surface proteins
were biotinylated by incubating cells with 0.5 mg/ml sulfo-NHS-LS-
biotin (Pierce) in PBSCM for 10 min at 4°C. Biotinylation was termi-
nated by incubation with 20 mM glycine in PBSCM at 4°C for 10 min,
followed by extensive washing with PBSCM. Biotinylated cells were then
lysed for 30 min in 50 mM Tris-HCl buffer, pH 7.5, containing 150 mM
NaCl, 0.5%TritonX-100, 1mMNaF, 2mMNa3VO4, 0.1mMPMSF, 1mM
Na4P2O7, 1 mM EDTA, and EDTA-free Protease Inhibitor Cocktail
(Roche) and centrifuged at 700 g for 15 min at 4°C. The supernatants
were collected and protein concentrations were determined using the
BCA kit (Pierce). The amounts of surface-localized proteins were deter-
mined by precipitating biotinylated proteins with streptavidin-coupled
agarose beads (Pierce) applied to the supernatants at 4°C overnight. Aga-
rose beadswere pelleted by centrifugation andwashed twicewith the lysis
buffer. Precipitated proteins were solubilized by the addition of 2
Laemmli buffer to the agarose beads and analyzed by Western blot.
Subcellular fractionation and isolation of lipid-enriched microdomains.
Lipid rafts were prepared from the crude membrane fraction of brain
homogenates of 2- to 3-month-old mice as described previously
(Leshchyns’ka et al., 2003).
Immunohistochemistry. Tissue preparation and immunohistochemis-
try on cerebella of youngC57BL/6mice was done as described previously
(Jakovcevski et al., 2009).
Spinal cord injury. Three-month-old femalemice were anesthetized by
intraperitoneal injection of ketamine and xylazine [100 mg of Ketanest
(Parke-Davis/Pfizer) and 5 mg of Rompun (Bayer, Leverkusen, Ger-
many) per kilogramof bodyweight]. Laminectomywas performed at the
T7–T9 level with mouse laminectomy forceps (Fine Science Tools). A
mouse spinal cord compression device was used for compression injury
(Curtis et al., 1993). Compression force (degree of closure of the forceps)
and duration were controlled by an electromagnetic device. The spinal
cord was maximally compressed [100%, according to the operational
definition of Curtis et al. (1993)] for 1 s by a time-controlled current flow
through the electromagnetic device. The skin was then surgically closed
using 6-0 nylon stitches (Ethicon). After surgery, mice were kept in a
heated room (35°C) for several hours to prevent hypothermia and then
housed singly in a temperature-controlled (22°C) room with water and
standard food provided ad libitum. After the surgery, bladders of the
animals were manually voided twice daily.
Histological analysis of the spinal cords. Mice were transcardially per-
fused with fixative consisting of 4% formaldehyde and 0.1%CaCl2 in 0.1
M cacodylate buffer, pH 7.3, for 15 min at room temperature. After
perfusion, the spinal cords were dissected out and postfixed overnight at
4°C in the same solution as used for perfusion and then cryoprotected in
15% sucrose solution in 0.1 M cacodylate buffer, pH 7.3, for 2 d at 4°C.
Pieces of spinal cords 1 cm in length centered at the lesion site were
embedded in Tissue Tek (Sakura Finetek), and frozen by 2 min immer-
sion into 2-methyl-butane (isopentane) precooled to 80°C. Serial
longitudinal sections were cut in a cryostat (CM3050; Leica), and
25-m-thick sections were collected on SuperFrost Plus glass slides
(Roth). Spaced serial sections 250 m apart were stained with cresyl
violet/luxol fast blue and used for estimations of the scar volume
using the Cavalieri principle. Areas of the scar required for volume
estimation were measured directly under the microscope using Neu-
rolucida software (MicroBrightField). Immunofluorescence labeling
of the spinal cord tissue with anti-5-HT and anti-TH antibodies was
performed as described previously (Jakovcevski et al., 2007).
Analysis of locomotor function. The recovery of ground locomotionwas
evaluated using the Basso, Beattie, Bresnahan (BBB) rating scale (Basso et
al., 1995)modified formice (Joshi and Fehlings, 2002) and a novel single-
frame motion analysis (Apostolova et al., 2006). This method includes
evaluation of four parameters in three different tests: beam walking
(foot-stepping angle and rump-weight index), voluntary movements
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without body weight support (extension-flexion ratio), and inclined lad-
der climbing (number of correct steps). Assessment was performed be-
fore and at 1, 3, and 6 weeks after the injury. Values for the left and right
legs were averaged.
Results
Proteolysis of Caspr is enhanced in brains of
PrP-deficient mice
Since PrP is highly expressed in the developing brain and regu-
lates neurite outgrowth (Graner et al., 2000; Lopes et al., 2005;
Santuccione et al., 2005; Lima et al., 2007), we analyzed whether
PrP deficiency is accompanied by changes in levels of adhesion
molecules in brains of PrP-deficient (PrP/) versus wild-type
(PrP/) mice. Western blot analysis with antibodies against the
intracellular domain of Caspr showed that levels of full-length
Caspr with the molecular weight of 180 kDa were approxi-
mately twofold lower in PrP/ versus PrP/ brain homoge-
nates from adult mice (Fig. 1A). A reduction in full-length Caspr
protein levels in PrP/ brain homogenates was accompanied by
an increase in levels of a degradation product of Caspr with the
molecular weight of 50 kDa (Fig. 1A). Since PrP, as a GPI-
anchored protein, accumulates in lipid rafts, we also analyzed
Caspr levels in lipid rafts isolated from PrP/ and PrP/
brains. Similar to the results with brain homogenates, levels of
full-length Caspr were decreased while levels of the 50 kDa deg-
radation product of Caspr were increased in PrP/ versus
PrP/ lipid rafts from the brains of adult mice (Fig. 1B). Caspr
degradation was also increased in the brains of young, 10-d-old
PrP/mice when comparedwith young PrP/mice (Fig. 1C).
In the young animals, however, intermediate degradation prod-
ucts of100 kDawere also present, butwere increased in PrP/
brains (Fig. 1C). Thus, our observations indicate that PrP
deficiency results in enhanced proteolytic processing of Caspr
in developing and mature brains. In contrast, levels of the
neural cell adhesion molecule NCAM were upregulated (San-
tuccione et al., 2005), while levels of the cell adhesion mole-
cules contactin (Fig. 1) and L1 (data not shown) were not
significantly affected by PrP deficiency.
Caspr is a novel binding partner for PrP
To analyze whether Caspr interacts with PrP, coimmunoprecipi-
tation experiments were carried out. Caspr coimmunoprecipi-
tated with PrP from lysates of adult (Fig. 2A) and young (Fig. 2C)
mouse brains. Conversely, PrP coimmunoprecipitated with
Caspr from lysates of young 10-d-old mouse brains (Fig. 2B).
These observations thus suggest that the two proteins interact
with each other in the developing and mature brain. Contactin
did not coimmunoprecipitate with PrP (Fig. 2A,C) and PrP did
not coimmunoprecipitate with contactin (Fig. 2C), underscoring
the specificity of the interaction of Caspr with PrP. This observa-
tion also suggests that PrP and contactin form two different com-
plexes with Caspr. Binding of Caspr to contactin was stronger
than that of Caspr to PrP, as shown by coimmunoprecipitation
efficiency of these complexes from brain lysates of 10-d-old mice
(Fig. 2C).While11.6 1.57% of all Caspr molecules coimmu-
noprecipitated with contactin,6.65 1.79% of all Caspr mol-
ecules coimmunoprecipitated with PrP.
Since coimmunoprecipitation experiments do not exclude
the possibility that two proteins are linked by intermediate
binding partners, we analyzed whether Caspr directly binds to
PrP by ELISA. Indeed, Caspr purified from mouse brain
bound to PrP-Fc in a concentration-dependent manner (Fig.
2D). In contrast, Caspr did not bind to BSA or L1-Fc analyzed
in parallel (Fig. 2D).
Indirect immunofluorescence labeling of early postnatal cer-
ebellar neurons maintained in culture for 24 h, i.e., the time of
active neurite outgrowth, showed that PrP partially colocalized
with Caspr along neurites, and both proteins were highly ex-
pressed in growth cones, where they also partially colocalized
(Fig. 2E). Furthermore, when Caspr was clustered at the cell sur-
face with antibodies against the extracellular domain of Caspr
applied to live neurons, PrP was partially redistributed to Caspr
clusters (correlation coefficients between the distributions of PrP
andCaspr were 0.25 0.02 and 0.58 0.04 for nonclustered and
clustered Caspr, respectively) (Fig. 2F,G), suggesting that Caspr
Figure 1. Proteolysis of Caspr is increased in PrP/ brains. A–C, PrP/ and PrP/
brain homogenates (A, adult animals; C, young, 10-d-old animals) and lipid rafts (B, adult
animals) were probed by Western blot with polyclonal antibodies against Caspr intracellular
domain. Note that levels of the full-length 180 kDa Caspr are reduced,while levels of the 50 kDa
degradation product of Caspr are increased in PrP/ brains and lipid rafts. In the brains of
young animals, intermediate degradation products of100 kDa are also observed. Graphs
show quantitation of the blots (mean SEM, n 5). Levels of full-length (FL) and a sum of
degradation products (DP) of Casprwere normalized to the total Caspr level, defined as a sumof
full-length and degradation product levels set to 100%. Labeling for contactin served as a
loading control. *p 0.05, paired t test.
Devanathan et al. • PrP Inhibits Caspr Shedding J. Neurosci., July 7, 2010 • 30(27):9292–9305 • 9295
associates with PrP at the cell surface. In contrast, clustering of
Caspr did not induce redistribution of tubulin (Fig. 2G).
In support of our immunocytochemical data, Caspr and PrP
were enriched in the growth cone fraction when compared with
total membrane fraction or total brain homogenates prepared
from youngmouse brains (Fig. 2H). Similarly, contactin was also
enriched in growth cones (Fig. 2H).
PrP inhibits shedding of Caspr from the cell surface
Themolecular weight of the intracellular domain of Caspr is10
kDa. Hence, the cleavage product of 50 kDa recognized by
antibodies against the C-terminal part of the Caspr intracellular
domain should include the whole intracellular and transmem-
brane domains and the cell surface membrane-adjacent portions
of Caspr. The occurrence of this degradation product, therefore,
suggested that the extracellular domain of Caspr should be re-
leased from the cell surface. To verify this idea, we analyzed
Caspr/ and Caspr/ brain homogenates by Western blot
with polyclonal antibodies against a peptide at the N terminus of
Caspr. Labeling with these antibodies revealed a degradation
product of Caspr with themolecular weight of50 kDa also (Fig.
3A). Since a single degradation product of 50 kDa could not
contain two epitopes located at opposite parts of the 190 kDa
full-length Caspr protein, the only explanation for this observa-
tion is that processing of Caspr includes its cleavage at several
sites (at least two) within its extracellular domain. Such cleavage
could then result in the release of Caspr fragmentswithmolecular
weights of 50 kDa. The occurrence of intermediate 100 kDa
cleavage products (Fig. 1C) further supports this idea.
Cleavage of cell surface-expressed Caspr within its extracellu-
lar domain should result in the release of extracellular domain
fragments to the extracellular space, resulting in the shedding of
Caspr from the cell surface. To verify that this occurs, medium
from cultured cerebellar neurons was analyzed by Western blot
with polyclonal antibodies against the N terminus of Caspr. In-
deed, the culture medium from Caspr/ neurons contained a
Caspr degradation product with the molecular weight of 50
kDa that was recognized by antibodies against the N terminus of
Caspr (Fig. 3B). This degradation product was not present in the
culturemedium fromCaspr/ neurons (Fig. 3B), indicating the
specificity of the labeling. Importantly, levels of the Caspr degra-
dation product were increased in the culture medium from
PrP/ versus PrP/ neurons (Fig. 3B). Furthermore, levels of
Caspr were reduced at the cell surface of PrP/ versus PrP/
neurons that were labeled by indirect immunofluorescence with
polyclonal antibodies against epitopes in the extracellular do-
main of Caspr (mean levels  SEM of surface Caspr along neu-
rites were 139.9 9.5 and 80 8.6 arbitrary units in PrP/ and
PrP/ neurites, respectively; arbitrary units were defined as
pixel values from the gray scale fluorescence images used for
quantitation; *p 0.05, t test) (Fig. 3C). In contrast, levels of L1
at the neuronal cell surface were similar in PrP/ and PrP/
neurons (mean levels SEMof L1 were 126.8 4.2 and 127.9
3.8 arbitrary units in PrP/ and PrP/ neurons, respectively;
p 0.05, t test).
To verify the role of PrP in inhibiting shedding of Caspr from
the cell surface, we transfected CHO cells, which do not express
Caspr or PrP, with cDNAs encoding these proteins. For compar-
ison, CHO cells were also transfected with contactin, which has
been shown to enhance Caspr levels at the cell surface (Faivre-
Sarrailh et al., 2000). Cell surface proteins in transfected cells
were then biotinylated and separated from the total protein pool
using streptavidin-agarose. Western blot analysis of the total and
biotinylated protein fractions with polyclonal antibodies against
the intracellular domain of Caspr showed that levels of Caspr at
the cell surface were approximately threefold higher in cells co-
transfected with Caspr and PrP versus cells transfected with
Figure 2. PrP directly interacts with Caspr. A–C, PrP/ brain homogenate (BH) and im-
munoprecipitates (IP) with PrP, Caspr, or contactin (Cont.) antibodies prepared using PrP/
brain lysate were analyzed by Western blot with antibodies against PrP, the intracellular do-
mainof Caspr, and contactin.Note that Caspr coimmunoprecipitateswithPrPandcontactin, but
contactin and PrP do not coimmunoprecipitate with each other. Mock immunoprecipitation
fromPrP/brain lysate (A) orwith nonspecific Igs (IgG) (B, C)was performed to control for IP
specificity. D, PrP-Fc, L1-Fc, or BSA was immobilized on a plastic surface and assayed for its
ability to bind increasing concentrations of Caspr purified from adultmouse brain. Mean values
of optical density (OD) SEM are shown. PrP-Fc, but not L1-Fc or BSA, bound to Caspr in a
concentration-dependent manner. E, F, Cultured cerebellar neurons were fixed with 4% para-
formaldehyde and labeled with antibodies against PrP and Caspr extracellular domain (E).
Alternatively, these antibodies were applied together to live neurons to cluster Caspr and PrP,
and then neurons were fixed (F ). Representative neurites are shown. Note that PrP and Caspr
partially colocalize with each other along neurites, and both proteins accumulate in growth
cones (E, arrowheads). Note also that clustering of proteins induces redistribution of Caspr and
PrP to overlapping clusters, suggesting that they are associated. Scale bar, 10 m. G, Graph
shows correlation coefficients (mean  SEM) between the distributions of PrP, Caspr, and
tubulin, which were labeled in fixed neurons or in neurons incubated live with Caspr and PrP
antibodies to cluster these proteins. *p 0.05, t test.H, Brain homogenates (BH), total mem-
brane fractions (MF), and growth cones (GC) were probed by Western blot with antibodies
against Caspr, PrP and contactin. Note that all three proteins accumulate in the growth cone
fraction.
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Caspr alone (Fig. 3D). Interestingly, cotransfection with PrP pro-
moted accumulation of Caspr at the cell surface to even higher
levels than cotransfection of Caspr with contactin (Fig. 3D). Al-
together, our data indicate that the cleavage of Caspr occurs at the
cell surface, resulting in shedding ofCaspr, and that this process is
regulated by PrP,which inhibits the proteolytic cleavage ofCaspr.
PrP inhibits serine protease-mediated proteolysis of Caspr at
the cell surface
To identify the proteases that are involved in shedding of Caspr
from the cell surface, we assayed the release of the 50 kDa frag-
ment from cultured cerebellar neurons treated with inhibitors of
different classes of proteases. Western blot analysis of culture
supernatants with polyclonal antibodies against the extracellular
domain of Caspr showed that inhibitors of the matrix metallo-
proteases GM6001 and phenanthroline and the inhibitor of as-
partic proteases pepstatin had no effect on the shedding of Caspr.
In contrast, the inhibitor of serine proteases, aprotinin, strongly
inhibited the release of the 50 kDa fragment of Caspr into the
culturemedium (Fig. 4A). Caspr sheddingwas inhibited by apro-
tinin in cultures of PrP/ and PrP/ neurons (Fig. 4B). To
investigate whether PrP inhibits the activity of a serine protease
that cleaves Caspr at the cell surface, we treated PrP/ and
PrP/ neurons with PrP-Fc applied in the culture medium.
Similar to aprotinin, PrP-Fc strongly inhibited the release of the
50 kDa fragment to the culture medium (Fig. 4C).
Figure 3. PrP increases cell surface expression of Caspr. A, Caspr/ and Caspr/ brain
homogenates were probed byWestern blot with polyclonal antibodies (N15) against a peptide
at the N terminus of Caspr extracellular domain. Note that the full-length 180 kDa product and
the 50 kDa degradation product of Caspr are recognized in Caspr/ but not in Caspr/
brain homogenates. B, Culture medium from Caspr/ and Caspr/ (top) or PrP/ and
PrP/ (bottom) cerebellar neuronswas analyzed byWestern blot with polyclonal antibodies
against Caspr extracellular domain. Note that these antibodies recognize the 50 kDa degrada-
tion product of Caspr in the culture medium from Caspr/ but not Caspr/ neurons. The
level of this band is increased in the culture medium from PrP/ versus PrP/ neurons.
Labeling for close homolog of L1 (CHL1), which is also released into the culturemedium, served
as a loading control.C, CulturedPrP/andPrP/ cerebellar neuronswere labeled livewith
polyclonal antibodies against Caspr extracellular domain.Note reduced levels of Caspr at the cell
surface of PrP/ versus PrP/ neurites. Scale bar, 10m. D, CHO cells were transfected
with Caspr alone or cotransfected with Caspr and PrP or contactin (cont.). Cell surface proteins
were then biotinylated on live cells and separated via streptavidin-coated beads from the total
protein pool following cell lysis. Samples containing cell surface proteins (biot.) and total cell
lysates (lysate) were then probed by Western blot with polyclonal antibodies against Caspr
intracellular domain, PrP, and contactin. Labeling for the FGF receptor (Flg) served as a loading
control. Higher levels of cell surface-biotinylated Caspr are observed in the samples of cells
cotransfectedwith Caspr and PrPwhen comparedwith Caspr-only transfected cells. Cell surface
Caspr levels are also higher in contactin and Caspr cotransfected versus Caspr-only transfected
cells, although this effect is less prominent than in Caspr and PrP cotransfected cells. Graph
shows quantitation of the blots (mean SEM, n	 3) with the signal from Caspr-only trans-
fected cells set to 100%. *p 0.05, paired t test.
Figure 4. PrP inhibits serine protease-mediated proteolysis of Caspr at the cell surface.
A, Culture medium collected from PrP/ cerebellar neurons nontreated or treated with in-
hibitors of matrix metalloproteases (GM6001 or phenanthroline), aspartic proteases (pepsta-
tin), or serine proteases (aprotinin) was analyzed by Western blot with polyclonal antibodies
against the extracellular domain of Caspr. Only aprotinin decreases levels of the 50 kDa degra-
dation product of Caspr in the culture medium. Labeling for L1 served as a loading control.
B, Culture medium collected from PrP/ and PrP/ cerebellar neurons nontreated or
treated with aprotinin was analyzed by Western blot with polyclonal antibodies against the
extracellular domain of Caspr. Labeling for L1 served as a loading control. Note that aprotinin
reduces levels of the 50 kDaCaspr degradationproduct in PrP/ andPrP/neurons. Graph
showsquantitationof theblots (meanSEM,n	3)with the signal fromnontreatedPrP/
neurons set to 100%. *p 0.05, paired t test. C, Culture medium collected from PrP/ or
PrP/ cerebellar neurons nontreated or treated with PrP-Fc was analyzed by Western blot
with polyclonal antibodies against Caspr extracellular domain. Labeling for L1 served as a load-
ing control. Note that PrP-Fc application reduces levels of the 50 kDa degradation product of
Caspr in the culture medium.
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Reelin is involved in Caspr proteolysis
Reelin, an extracellular matrix glycoprotein and serine protease,
is highly expressed during brain development (Rice and Curran,
2001; Tissir and Goffinet, 2003), and its proteolytic activity is
inhibited by aprotinin (Quattrocchi et al., 2002). Interestingly,
Reelin cleaves its substrates, such as fibronectin or laminin, at
several sites releasing several smaller fragments (Quattrocchi et
al., 2002), making it a plausible candidate for cleavage of Caspr,
which also contains laminin-like domains in its structure. West-
ern blot analysis with Reelin antibodies showed that Reelin accu-
mulates in the growth cone fraction (Fig. 5A), which is also
enriched in Caspr and PrP (Fig. 2H). The levels of the full-length
Reelin with the molecular weight of400 kDa were decreased in
PrP/ versus PrP/ brain homogenates (Fig. 5B). A decrease
in the levels of full-length Reelin was accompanied by an increase
in the levels of its autoproteolytic degradation product with the
molecular weight of140 kDa by 93 32% (*p 0.05, n	 3,
paired t test) in PrP/ brain homogenates (Fig. 5B). This deg-
radation product of Reelin possesses higher proteolytic activity
than the full-length Reelin (Quattrocchi et al., 2002). These ob-
servations suggest that the proteolytic activity of Reelin is in-
creased in PrP/ versus PrP/ brains.
To analyze the role of Reelin in Caspr cleavage, we compared
Caspr levels in Reelin-deficient (Reelin/) and wild-type (Ree-
lin/) mice. Western blot analysis of the brain homogenates
showed that production of the 50 kDa Caspr fragment was not
significantly reduced in Reelin/ versus Reelin/ brains
(16.97  2.45% versus 19.24  2.4% of the total Caspr level in
Reelin/ and Reelin/mice, respectively) (Fig. 5C). Remark-
ably, levels of PrPwere reduced by 46.7 3.4% (*p 0.05, n	 3,
paired t test) in Reelin/ versus Reelin/mice (Fig. 5C), fur-
ther suggesting a relationship between Reelin and PrP. Since re-
duced expression of PrP is associated with Caspr proteolysis (Fig.
1A–C), this may explain the relatively mild effect of Reelin defi-
ciency onCaspr degradation, suggesting that under conditions of
reduced PrP expression Caspr is cleaved by other proteases in
Reelin/ brains.
To analyze the effect of Reelin on Caspr levels in amore direct
manner, we transfected CHO cells with Caspr alone or cotrans-
fected themwith Caspr together with Reelin or PrP.Western blot
analysis of CHO cell lysates showed that levels of full-length
Caspr were increased in cells cotransfected with Caspr and PrP
versus cells transfected with Caspr alone (Fig. 6A). This observa-
tion is in accordance with our results in PrP/ and PrP/
brain homogenates (Fig. 1). In CHO cells cotransfected with
Caspr and Reelin, levels of full-length Caspr were drastically re-
duced (Fig. 6A), being accompanied by an increase in levels of the
extracellular 50 kDa Caspr fragment in cell lysates and culture
medium, further suggesting that Reelin is involved in proteolysis
of Caspr at the cell surface. In contrast, Reelin-mediated Caspr
proteolysis was inhibited in CHO cells cotransfected with Caspr
together with Reelin and PrP (Fig. 6A), indicating that PrP inhib-
its Reelin-mediated proteolysis of Caspr.
Unlike PrP, contactin did not inhibit Caspr proteolysis in
transfected CHO cells. On the contrary, full-length Caspr levels
were reduced in CHO cells cotransfected with contactin (Fig.
6B). Caspr proteolysis was further enhanced in cells overex-
pressing contactin together with Reelin (Fig. 6B). A plausible
explanation for this observation is that contactin-mediated
delivery of Caspr to the cell surface (Fig. 3D) results in expo-
sure of Caspr to extracellular proteases, such as Reelin, fol-
lowed by Caspr degradation in the absence of protective, i.e.,
degradation-preventing, PrP.
In accordance with our data from transfected CHO cells, in-
cubation of the recombinant extracellular domain of Caspr fused
to human Fc (Caspr-Fc) with recombinant Reelin also resulted in
a reduction in levels of full-length Caspr-Fc (Fig. 6C). A reduc-
tion in full-length Caspr-Fc levels was accompanied by an in-
crease in levels of its 50 kDa degradation product in the probes
incubated with Reelin (Fig. 6C). A similar effect was observed
when Caspr purified from mouse brain was incubated with re-
combinant Reelin (data not shown). Reelin, however, did not
have any effect on levels of L1 analyzed in parallel (Fig. 6C).
Finally, we analyzedwhether Caspr, PrP, andReelin colocalize
in the brain by immunohistochemically analyzing brain sections
from 10-d-old wild-type mice. All three proteins were highly ex-
pressed in the cerebellum (Fig. 7). Colabeling with the antibodies
Figure 5. Reelin accumulates in growth cones, and levels of its active form are in-
creased in PrP/ brains. A, Brain homogenates (BH), total membrane fractions (MF),
and growth cones (GC) were probed by Western blot with antibodies against Reelin. Note
that Reelin accumulates in the growth cone fraction. B, PrP/ and PrP/ brain ho-
mogenates were probed by Western blot with antibodies against Reelin. Note decreased
levels of the full-length 400 kDa Reelin and increased levels of the 140 kDa form of Reelin
in PrP/ versus PrP/ brain homogenates. Actin served as a loading control.
C, Reelin/ and Reelin/ brain homogenates were probed by Western blot with antibodies
against PrP and Caspr. Note decreased levels of PrP in Reelin/ versus Reelin/ brain homoge-
nates. Actin served as a loading control.
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to calbindin, a marker of Purkinje cells, showed that Caspr is
highly expressed in this cell type (Fig. 7A). At slightly lower levels
than in Purkinje cells, Caspr was also present in the molecular
and granular layers of the cerebellum (Fig. 7A,B). PrP and Reelin
were also expressed in the molecular and granular layers of the
cerebellum but were undetectable in Purkinje cells (Fig. 7A). Co-
labelingwith antibodies against Caspr andReelin showed that the
distributions of the two proteins highly overlapped in the molec-
ular and granular layers of the cerebellum (Fig. 7B). Similarly,
Caspr distribution highly overlappedwith the distribution of PrP
in the molecular and granular layers (Fig. 7B). In summary, our
observations suggest that functional interactions between Caspr,
PrP, and Reelin also take place in vivo.
Caspr inhibits neurite outgrowth of cerebellar neurons
WhileCaspr is highly expressed in growing cerebellar (Figs. 2C,D,
3C, 7) and hippocampal neurons (data not shown), its functional
role in neurite outgrowth remains poorly
understood. High levels of Caspr in
growth cones of neurites suggest that
Caspr may play a role in the regulation of
neurite outgrowth. To analyze this possi-
bility,wecomparedneuriteoutgrowth from
cerebellar neurons of Caspr/ and
Caspr/mice maintained on glass cover-
slips coated with poly-L-lysine alone or
in combination with laminin or PrP-Fc.
Strikingly, 24 h after plating, neurites of
Caspr/ neurons were longer than those
of Caspr/ neurons on all substrates
tested (Fig. 8A), suggesting that interac-
tions of Caspr at the neuronal cell surface
with substrate-coated poly-L-lysine, which
may also attract molecules released
from the cultured cells or present in the
culture medium, inhibit neurite out-
growth. This effect was not compen-
sated by outgrowth-promoting agents
such as laminin or PrP-Fc. To confirm
this, we maintained Caspr/ neurons
on glass coverslips coated with poly-L-
lysine alone or in combination with three
different polyclonal antibodies against
different epitopes in the extracellular do-
main of Caspr. These antibodies reduced
neurite outgrowth compared with neurite
outgrowth on poly-L-lysine alone (Fig.
8B). One possible explanation of this re-
sult is that Caspr antibodies protect Caspr
from cleavage. However, levels of full-
length Caspr were similar in cultures
treated with Caspr antibodies or control
nonspecific Igs (Fig. 8C). Therefore, our
results suggest that binding of Caspr to ex-
tracellular ligands, such as substrate-coated
antibodies, inhibits neurite outgrowth by
triggering intracellular signaling events.
Again, antibodies against the extracellular
domain of Caspr inhibited neurite out-
growth even in the presence of the out-
growth promoting agents, such as laminin
or PrP-Fc (Fig. 8D). Neurite outgrowth
from Caspr/ neurons analyzed for con-
trol was not affected by polyclonal antibodies against the extracellu-
lar domain of Caspr (Fig. 8D), showing the specificity of the effect
exerted by the antibodies.
PrP deficiency attenuates the inhibitory effect of Caspr on
neurite outgrowth
Since PrP deficiency results in reduced levels of Caspr at the
neuronal surface,wecomparedneuriteoutgrowth fromPrP/and
PrP/ cerebellar neurons in vitro. Similar to Caspr/ neurons,
PrP/ neurons extended neurites better than PrP/ neurons in-
dependently of whether neurons were grown on poly-L-lysine alone
or in combination with laminin or PrP-Fc (Fig. 9A). Addition of
aprotinin to the culture medium, however, negated this differ-
ence (Fig. 9A). In view of our results on shedding of Caspr from
the neuronal cell surface, a plausible explanation for this obser-
vation could be that increased Caspr shedding from PrP/ neu-
rons relieves Caspr-mediated inhibition of neurite outgrowth,
Figure 6. PrP but not contactin inhibits Reelin-mediated Caspr proteolysis. A, CHO cells were transfected with Caspr
alone, or cotransfected with Caspr and PrP or Reelin as indicated. Cell lysates were then analyzed with antibodies against
Reelin, PrP, Caspr intracellular domain, and FGFR1 (FLG) as a loading control. Culturemediumwas analyzedwith antibodies
against the extracellular domain of Caspr. Note that levels of full-length Caspr are reduced in cells cotransfected with Caspr
and Reelin and that this effect is blocked in cells cotransfected with Caspr, Reelin, and PrP. Cotransfection with Reelin
results in the appearance of the 50 kDa degradation product of Caspr in lysates and culture medium. B, CHO cells were
transfected with Caspr alone or cotransfected with Caspr and contactin (Cont.) or Reelin as indicated. Cell lysates were then
analyzed with antibodies against Reelin, contactin, Caspr intracellular domain, and GAPDH as a loading control. Note that
Caspr proteolysis is enhanced in cells cotransfected with contactin. Graph shows quantitation of the blots (mean SEM,
n	 6). Full-length Caspr levels in cells transfected with Caspr without contactin and Reelin were set to 100%. *p 0.05,
paired t test. C, Caspr-Fc and L1 from mouse brain were incubated with Reelin-containing culture medium from CHO cells
transfected with full-length Reelin or medium from CHO cells transfected with pcDNA3 for control. Proteins were then
probed by Western blot with polyclonal antibodies against the extracellular domain of Caspr or L1, respectively. Note that
levels of full-length Caspr are reduced whereas levels of 50 kDa degradation product of Caspr are increased following
preincubation with Reelin. Reelin does not influence L1 levels. Graph shows quantitation of the blots (mean SEM, n	
3). Levels of full-length (FL) and 50 kDa degradation product (DP) of Caspr were normalized to the total Caspr level defined
as a sum of full-length and 50 kDa degradation product levels set to 100%. *p 0.05, paired t test.
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while aprotinin-mediated inhibition of
Caspr shedding negates the difference be-
tween PrP/ and PrP/ neurons.
To investigate this idea, we compared
the effects of Caspr on neurite outgrowth
from PrP/ and PrP/ neurons. In-
deed, while neurite outgrowth from
PrP/ neurons grown on poly-L-lysine
in combination with the antibodies
against the extracellular domain of Caspr
was reducedwhen comparedwith PrP/
neurons grown on poly-L-lysine alone,
Caspr antibodies had little effect on neu-
rite outgrowth from PrP/ neurons
(Fig. 9B). Similarly, polyclonal antibodies
against the extracellular domain of Caspr
had no effect on neurite outgrowth from
PrP/ neurons maintained on poly-L-
lysine together with laminin, but they in-
hibited neurite outgrowth from PrP/
neurons maintained on this substrate
(Fig. 9B). Antibodies against the intracel-
lular domain of Caspr analyzed for con-
trol did not influence neurite outgrowth
from PrP/ neurons, indicating the
specificity of the observed effects (Fig.
9B). The combined observations show
that PrP deficiency results in reduced re-
sponsiveness of neurons to Caspr ligands,
such as antibodies, correlating with re-
duced levels of Caspr at the surface of
PrP/ neurons.
Finally, we analyzed the responsive-
ness of neurons to recombinant Reelin
applied in the culture medium. Reelin
produced by transiently transfected CHO
cells, but not conditioned medium from
mock-transfected control CHO cells, in-
creased neurite outgrowth in wild-type
neurons to the level of Caspr/ neurons
(Fig. 9C). Reelin, however, didnotpromote
neurite outgrowth in Caspr/ neurons
(Fig. 9C).Hence,Caspr shedding is themost
likely mechanisms by which Reelin pro-
motes neurite outgrowth in wild-type neu-
rons. Interestingly, Reelin induced an even
stronger effect in PrP/neurons (Fig. 9C),
suggesting that the effect of recombinant
Reelin is superimposed on the effect of en-
dogenous Reelin, showing higher activity in
PrP/ brains.
Increased Caspr proteolysis correlates with increased
locomotor recovery after spinal cord injury in PrP/ versus
PrP/mice
To analyze whether enhanced Caspr proteolysis correlates with
increased axonal outgrowth in vivo, we compared the behavior of
axons in spinal cords regenerating after thoracic compression
lesions in PrP/mice and their PrP/ littermates. Immuno-
histochemical analysis showed that in lesioned spinal cords of
PrP/ mice, PrP was broadly distributed at the lesion site and
rostrally to the lesion site (Fig. 10). Double labeling for PrP and
Caspr showed that both molecules colocalized at the paranodal
regions in the white matter of the injured PrP/ spinal cord
(Fig. 10) indicating that PrP may be involved in regulation of
Caspr function. In agreement with this idea, Western blot analy-
sis showed that the levels of activated 140 kDa Reelin autoproteo-
lytic degradation product sampled within the lesion site in
lesioned spinal cords were 86.7 33.3% higher in PrP/ versus
PrP/ animals (n 	 3, *p  0.05, paired t test) (Fig. 11A). An
increase in levels of activated, i. e., autoproteolytic, Reelin was
accompanied by a 43.5  4.95% reduction in full-length Caspr
levels and a proportional 80 13.3% increase in levels of the 50
kDa degradation product of Caspr at the lesion site in PrP/
mice (n 	 3, *p  0.05, paired t test) (Fig. 11A), indicating
Figure 7. Caspr colocalizeswith PrP and Reelin in the 10-d-oldmouse cerebellumby immunohistochemistry.A,B, Low (A) and
high (B) magnification images of the mouse cerebellum labeled with antibodies against Caspr, PrP, Reelin, and calbindin are
shown. Note, that Caspr is highly expressed in calbindin-positive Purkinje cells. Note also that Caspr colocalizeswith PrP andReelin
in the granular (GL) and molecular (ML) layers of the cerebellum. Bar, 100m (low magnification; in A), 40m (high magnifi-
cation; in B).
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enhanced proteolysis of Caspr. Interestingly, Western blot anal-
ysis showed that levels of full-length Caspr and its degradation
product were not different in noninjured spinal cords of PrP/
and PrP/ mice (supplemental Fig. S2, available at www.
jneurosci.org as supplemental material). Immunofluorescence
labeling of noninjured spinal cords showed that Caspr nearly
exclusively accumulated at paranodal regions in noninjured spi-
nal cords of both PrP/ and PrP/ mice (supplemental Fig.
S2, available at www.jneurosci.org as supplemental material).
Together, these data suggest that PrP protects Caspr when it is
located outside of the paranodes in growing or regenerating ax-
ons, while the protective role of PrP is diminished in paranodes.
The presence of the 50 kDa degradation product in the mature
noninjured spinal cords, however, indicates that proteolytic pro-
cessing of Caspr also takes place in paranodes, probably indepen-
dently of PrP.
Enhanced proteolysis of Caspr at the sites of spinal cord lesion
in PrP/mice correlated with increased numbers of axons cau-
dal to the lesion site in PrP/ versus PrP/ animals. Numbers
of catecholaminergic (TH) and serotonergic (5-HT) axons
beyond an arbitrarily selected border 250mcaudal to the lesion
site 6 weeks after the injury were twofold higher in PrP/ versus
PrP/ mice (Fig. 11B). The increase in the number of axonal
fibers caudally to the lesion site, representing either axons that
have grown through the lesion site or newly formed branches of
the spared axons, thus suggests a more conducive tissue environ-
ment for axonal growth in regenerating spinal cord of PrP/
versus PrP/mice. It is unlikely that this increase in the number
of regenerated axons was due to a lower susceptibility to damage
or astrogliotic scarring in PrP/mice, since themean volume of
the lesion scar in PrP/ and PrP/mice was similar at 6 weeks
after injury (1.25 0.11 vs 1.35 0.14 mm3; p 0.05, t test).
Next, recovery of locomotor functions in PrP/ mice and
their PrP/ littermates was assessed at several time points after
spinal cord lesion. Spinal cord compression caused severe disabil-
ities in both PrP/ and PrP/ mice, as assessed by the BBB
score 1 week after injury (Fig. 11C). Between 1 and 6 weeks after
the lesion, locomotor function improved in both genotypes, but
improvement was greater in PrP/ mice than in their PrP/
littermates as estimated not only by BBB score values but also by
Figure 8. Caspr is involved in inhibition of neurite outgrowth. A, Graph shows neurite
lengths (mean SEM, n	 300) from Caspr/ and Caspr/ cerebellar neurons main-
tained in culture on poly-L-lysine (PLL) substrate coated on glass coverslips alone, or in conjunc-
tion with laminin or PrP-Fc. Neurite lengths are increased in Caspr/ neurons versus
Caspr/ neurons on all substrates. *p  0.05, t test. B, Graph shows neurite lengths
(mean SEM, n	 300) in Caspr/ cerebellar neuronsmaintained on PLL substrate coated
on glass coverslips in conjunction with laminin alone or together with polyclonal antibodies
against three peptides in the extracellular domain of Caspr (L17, N15, and L23). Neurite lengths
are decreased inneurons grown in thepresence of Caspr antibodies. *p0.05, t test.C, Lysates
of cultured cerebellar neurons maintained on poly-L-lysine substrate coated with nonspecific
rabbit Igs (IgG) or Caspr antibodies (L23) probed byWestern blot with antibodies against Caspr
and L1. Note that the levels of full-length Caspr are similar in both groups. The experiment was
performed twicewith the sameeffect.D, Graph showsneurite lengths (mean SEM,n	300)
in Caspr/ and Caspr/ cerebellar neurons maintained on PLL substrate coated on glass
coverslips alone or in conjunction with laminin, PrP-Fc, nonspecific rabbit IgG, or antibodies
against the extracellular domain of Caspr (L17). Neurite lengths are decreased in Caspr/ but
not in Caspr/ neurons grown in the presence of Caspr antibodies. *p 0.05, t test.
Figure 9. PrP/ neurons are less responsive than PrP/ neurons to Caspr-mediated
inhibition of neurite outgrowth.A, Graph shows neurite lengths (mean SEM, n	 300) from
PrP/andPrP/ cerebellar neuronsmaintainedonpoly-L-lysine (PLL) substrate coatedon
glass coverslips alone or in conjunction with laminin or PrP-Fc. Neurons were grown in either
the presence or absence of aprotinin. In the absence of aprotinin, neurites in PrP/ neurons
are longer than those in PrP/ neurons. This effect is lost in the presence of aprotinin. *p
0.05, t test. B, Graph shows neurite lengths (mean SEM, n	 300) in PrP/ and PrP/
cerebellar neurons maintained on PLL substrate coated on glass coverslips alone or in conjunc-
tion with laminin, nonspecific rabbit immunoglobulins (IgG), antibodies against the extracel-
lular (L23), or intracellular domain of Caspr. Note that antibodies against the extracellular
domain of Caspr inhibit neurite outgrowth in PrP/ but not PrP/ neurons. *p 0.05, t
test. C, Graph shows neurite lengths (mean  SEM, n 	 70) in wild type, PrP/, and
Caspr/ cerebellar neurons maintained on PLL substrate coated on glass coverslips alone or
in conjunction with conditionedmedia from CHO cells transfected with Reelin or pcDNA3. Note
that Reelin promotes neurite outgrowth inwild-type and PrP/ but not Caspr/ neurons.
*p 0.05, t test.
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foot-stepping angle, rump-height index, and extension-flexion
ratio (Fig. 11C). Foot-stepping angle is a parameter that describes
plantar-stepping ability, previously shown to correlate well with
the BBB score, whereas rump-height index and extension-flexion
ratio measure the ability of lower limbs to support body weight
and perform voluntary movements without weight support, re-
spectively (Apostolova et al., 2006). PrP/ mice had better lo-
comotor functions at 3 and 6weeks after injury as estimated by all
measured parameters, indicating better preserved and/or rees-
tablished connections between the lumbar spinal cord and the
higher brain structures compared with their PrP/ littermates.
However, numbers of correct steps made by the animals during
inclined ladder climbing, reduced to approximately zero in both
genotypes 1 week after injury, did not improve with time in nei-
ther PrP/ nor PrP/ mice (data not shown). The ladder-
climbing test allows estimation of the ability to perform precise,
coordinated movements requiring the highest degree of su-
praspinal control, whichwas not reestablished after being severed
in either group ofmice. From our analysis, we conclude that after
spinal cord injury there is an overall improved recovery in
PrP/mice compared with their PrP/ littermates.
Discussion
In recent years, increasing interest has focused on the character-
ization of the role of the cellular form of PrP in neural cell inter-
actions. PrP is a ubiquitously expressed small glycoprotein that
displays functional properties of a cell adhesion molecule. It is
localized at the cell surface via a GPI anchor and hence accumu-
lates in cholesterol-enriched lipidmicrodomains or rafts. Interest
in PrP also derives from its involvement in prion diseases that are
caused by a conformationally altered insoluble form of PrP that ac-
cumulates in the brain as aggregates (Prusiner, 1998; Weissmann
and Flechsig, 2003). Mutations in PrP causing aggregate formation
have been linked to the Gerstmann–Stra¨ussler–Scheinker syn-
drome, familial fatal insomnia, sporadic Creutzfeld–Jakob disease,
and certain forms of dementia with cerebellar disorder and myop-
athy (Hsiao et al., 1989; Collinge, 1997).
In the present study we have investigated the functional inter-
play between PrP and two other glycoproteins involved in mor-
phogenetic events in the developing nervous system: Caspr and
Reelin. While the cellular form of PrP has been linked to neurite
outgrowth and neuronal survival (Graner et al., 2000; Zanata et
al., 2002; Chen et al., 2003; Santuccione et al., 2005; Lima et al.,
2007), the contactin-associated protein Caspr has not been di-
rectly linked to neurite outgrowth, although its direct interaction
with contactin would suggest such a function, since this GPI-
linked Ig superfamily adhesion molecule promotes axonal
growth (Falk et al., 2002). Caspr also interacts with the receptor-
like protein tyrosine phosphatase RTPT (Peles et al., 1997),
which inducesneuriteoutgrowthbybinding tocontactin (Sakurai et
al., 1997). Contactin, in turn, functionally interacts with 1 inte-
grin, a cell surface receptor for extracellular matrix ligands, an
interaction that has been reported to be neurite outgrowth pro-
moting (Treubert and Brummendorf, 1998). Caspr has been also
reported to associate with 1 integrin in the CNS (Denisenko-
Nehrbass et al., 2003). Caspr is further involved in a network of
interactions in that it inhibits the binding of contactin to the L1 Ig
familymolecule neurofascin (Gollan et al., 2003). However, until
now these interactions of Caspr with other molecules have been
viewed mainly in the context of neuron-glia interactions at the
node of Ranvier. As a third player in the neurite outgrowth reg-
ulating activities of PrP and Caspr, we introduce Reelin, an extra-
cellular matrix glycoprotein that has been studied in terms of
dendrite and axon development and neurogenesis (Hack et al.,
2002; Kim et al., 2002; Niu et al., 2004; Forster et al., 2006;Won et
al., 2006; Lorenzetto et al., 2008). A relation to neurite outgrowth
for Reelin is again indicated by its capacity to interact with inte-
grins (Dulabon et al., 2000; Schmid et al., 2005). Reelin also pro-
motes neurite outgrowth through its interactions with the very
low-density lipoprotein receptor and apolipoprotein E receptor
via tyrosine phosphorylation of disabled-1 (D’Arcangelo et al.,
1999; Hiesberger et al., 1999).
In the present study we show a novel relationship between
PrP, Caspr, and Reelin in the context of neurite outgrowth regu-
lation. Clustering of Caspr at the cell surface of cultured cerebel-
lar neurons inhibits neurite outgrowth, indicating that Caspr is a
negative regulator of neurite outgrowth. PrP, by its direct inter-
action with Caspr at the cell surface, inhibits Caspr shedding
from the cell surface, thereby potentiating the inhibitory effect of
Caspr in neurite outgrowth in vitro. This new role for PrP in
potentiation of neurite outgrowth inhibition does not contradict
previous data on its outgrowth-promoting activities. On the con-
trary, it suggests an interesting scenario in which PrP promotes
neurite outgrowth in the absence of Caspr activity. By maintain-
Figure 10. PrP and Caspr expression in the injured mouse spinal cord. A–C, Immunohisto-
chemistry for PrP (red) at the lesion site (A), 500mrostrally in the thoracic spinal cord (B), and
in the lumbar spinal cord graymatter (C).D, Immunohistochemistry for PrP at the lesion site of
a PrP/mouse spinal cord shows no specific staining. E, Double immunohistochemistry for
PrP (red) and caspr (green) in the white matter of the injured PrP/ spinal cord. F, Higher
magnification of the square in E. Arrows point to the nodes of Ranvier. On all panels nuclei are
counterstained with bisbenzamide (bb, blue). Scale bar: (in A) A–E, 20m; F, 10m.
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ing high Caspr levels at the cell surface, PrP allows neurites to
respond promptly to Caspr activation that would arrest neurite
outgrowth when the proper targets are reached.
In the present study, we confirmed Reelin’s function as a pro-
tease rather than as a ligand for integrins or lipoprotein receptors.
This proteolytic activity of Reelin (Quattrocchi et al., 2002) ap-
pears to play a role in regulating the Caspr-dependent inhibition
of neurite outgrowth of cerebellar neurons; in the absence of PrP,
Reelin proteolytically cleaves the extracellular domain of Caspr,
thus reducing the capacity of Caspr to decrease neurite out-
growth. The functions of the extracellular 50 kDa fragment of
Caspr produced by Reelin are not known, but it is possible that by
itself it also plays an outgrowth-promoting role. Interestingly,
levels of the activated 140 kDa Reelin proteolytic fragment are
increased in PrP-deficient brains. This observation suggests that
PrP not only protects Caspr fromReelin-mediated proteolysis by
directly associating with Caspr, but also that the activation of
Reelin is down regulated by unknown mechanisms in the pres-
ence of PrP. Whether these effects are dependent also on Caspr-
associated proteins, such as contactin, remains to be seen.
In the context of our study it is noteworthy that differentiation
of granule cells and cerebellar network formation is retarded in
PrP-deficient mice, confirming the role of PrP in brain develop-
ment (Prestori et al., 2008). In our present study, the potentiating
effect of PrP on inhibition of neurite outgrowth was tested not
only in vitro but also in vivo; in agreement
with our in vitro data, constitutive absence
of PrP in mice leads to enhanced regener-
ation after spinal cord injury in terms of
recovery of locomotor functions and re-
growth of serotonergic and adrenergic ax-
ons into the caudal part of the lesioned
spinal cord of adultmice. These results are
interpretable in the context of PrP’s ability
to enhance the inhibitory activity of Caspr
on neurite outgrowth by neutralizing the
Reelin-mediated proteolysis of Caspr. In
agreement with this, Reelin/ mice
show impaired nerve regeneration after
peripheral nerve injury (Lorenzetto et al.,
2008). Recent observations also provide
evidence that Reelin is expressed and se-
creted by oligodendrocytes (Osterhout
and Siebert, 2009). Our data call for anal-
ysis of axonal regrowth in Caspr-deficient
mice that should provide evidence of a
role for Caspr in inhibiting axonal re-
growth and locomotor recovery after spi-
nal cord injury. However, this experiment
could not be performed due to the very
high mortality of Caspr-deficient mice
within a week after the spinal cord injury.
Further research using more refined
methods of Caspr knock-down in vivo
should help to address this question.
Although the associations between
PrP, Caspr, and Reelin in vivo are likely to
be more complex than depicted in the
present study, we view our results on the
functional interplay between the three
molecules in vitro to allow our present in-
terpretation. It is unlikely that the en-
hanced recovery of locomotor functions
in spinal cord-lesioned PrP deficient mice are due to more gen-
eral abnormalities, since the anatomy of their CNS is apparently
normal and functional abnormalities in thesemice are very subtle
(Bueler et al., 1992). However, enhanced proteolytic activity in
PrP-deficient brains and in the CNS may well contribute to en-
hanced locomotor recovery after the spinal cord injury. Whether
other inhibitory molecules are targets of Reelin’s proteolytic ac-
tivity remains to be investigated.
In view of our findings, the observed abnormalities in the
reeler mutant and Caspr-deficient mice call for a comparison of
their phenotypes in the context of the functional interplay be-
tween Reelin, Caspr, and PrP. The molecular and cellular mech-
anisms underlying the ataxic behavior of reelermutant mice have
been attributed to cell migration defects in the cerebellar and
cerebral cortices (Magdaleno et al., 2002; Won et al., 2006). It is
not known, however, how these relate to the absence of the pro-
teolytic activity of Reelin. The ataxic defects of Caspr-deficient
mice have beenmostly related to the abnormal structure of nodes
of Ranvier in the central and peripheral nervous systems (Bhat et
al., 2001), but they also could be related in view of our present
observations in the context of an altered balance between neurite
outgrowth-promoting and neurite outgrowth-inhibitory cues.
The relation of these molecules to transmitter receptors, ion
channels, and ion transporters that have emerged recently as im-
Figure 11. Enhanced Caspr proteolysis at the spinal cord lesion site correlates with increased axonal outgrowth and improved
locomotor recovery in PrP/ versus PrP/ mice after spinal cord injury. A, Homogenates of the injured spinal cords from
PrP/ and PrP/mice sampled at the lesion site were probed byWestern blot with the indicated antibodies. Note decreased
levels of the full-length (FL) Caspr and increased levels of the 50 kDa degradation product (DP) of Caspr and 140 kDa form of Reelin
in PrP/ versus PrP/ samples. Actin served as a loading control. B, Graph shows numbers of catecholaminergic (TH) and
serotonergic (5HT) axons projectingbeyonda line drawn250mcaudally to the lesion site counted in spaced serial parasagittal
sections from the injured spinal cords of PrP/ and PrP/mice killed 6 weeks after injury. Note increased numbers of TH
and 5-HT fibers in PrP/ versus PrP/mice. *p 0.05, t test. C, Shown aremean SEM values of open-field locomotion
(BBB) scores, foot-stepping angles, rump-height indices, and extension-flexion ratios before surgery (d 0) and at 1, 3, and 6weeks
after spinal cord injury (SCI). *p 0.05, significant differences between group mean values at a given time period (one-way
ANOVA for repeated measurements with Tukey’s post hoc test; n	 10 mice per genotype).
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portant partners in recognition molecule function also needs to
be investigated.
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